In the realm of Veterinary medicine, just as in human medicine, there are always advancements being made and research being conducted. Especially in the realm of cannabis based therapies.
One of the front runners in that realm of cannabis and pure CBD oil research is Colorado State University’s Dr. Stephanie McGrath.
Dr. McGrath, who specializes in neurology, is leading a Colorado State University study on the efficacy of cannabidiol (CBD) for the treatment of epilepsy and osteoarthritis in dogs. A leading advocate for testing and researching CBD in the veterinary field, McGrath spoke about veterinary CBD trials and the science involved.
My wife is a Licensed Vet Tech, and has enlightened me to many advancements in the Veterinary community. CBD is a front runner in that realm and is gaining momentum among Veterinary Practices across the Nation. As Hemp CBD and medicinal cannabis laws change in favor of their use, it is allowing for great advancements in medicine.
“McGrath has spent her career treating seizure disorders and inflammatory brain diseases, as well as a variety of spinal cord disorders. So how did she end up pioneering CBD studies and information in the veterinary world?
Around 3 to 5 percent of all dogs have genetic epilepsy, she told the audience, and 14 million dogs are affected by arthritis. These serious, costly medical issues afflict humans as well. CBD isn’t the miracle cure-all for those suffering from such issues — whether humans or animals — but McGrath believes it can be an important alternative for both. She is currently running two trials at the CSU Veterinary Teaching Hospital, studying how effectively CBD can treat epilepsy and osteoarthritis in canines.
To participate in her studies, dogs must have arthritis affecting one or more joints and a visible lameness that has been present for at least four weeks. The purpose of the study is to assess the effectiveness of a component of CBD in treating canine osteoarthritis. The CBD product is very low in THC (always less than .3 percent), so that there are no psychoactive effects, making it safe for dogs to use, she said.”
As her research continues, it is very exciting to see what the possibilities of CBD are. We have already seen and heard so many testimonies of the positive impact CBD has had and is having on people, why not let our furry friends enjoy the same benefits.
It is not just Veterinary medicine that research and strides in the realm of CBD therapies. There are great strides being made in the realm of human medicine as well.
According to BizJournals.com, University of Alabama at Birmingham is making great strides in the field of CBD oil Research.
“Researchers at the University of Alabama at Birmingham have discovered evidence of interactions between cannabidiol oil, known better as CBD oil, with commonly used anti-epilepsy drugs.
The findings, published on Monday in Epilepsia, the journal of the International League Against Epilepsy, show the first indications of a potential drug with CBD oil. The substance is drawing great interest as a treatment for epilepsy.
The UAB Epilepsy Center launched a study of CBD oil in March 2015; the study was designed to test the safety and tolerability of CBD oil, which is a derivative of the cannabis plant. The patients in the 2015 study were receiving therapy for severe, intractable epilepsy in both adults and children. The study had patients taking CBD oil as well as their prescribed anti-epilepsy medicine as well.
The research team examined blood levels of 81 subjects enrolled in the CBD trials, 39 adults and 42 children, for concentrations of their existing medications. The most significant changes were an increase in the level of an anti- seizure medication, named clobazam, and its active metabolite. The changes were outside the accepted therapeutic range for both drugs. In addition, the research showed that a very small number of participants using the anti-seizure medication, had an increase in liver enzymes, indicating the potential for liver damage in a small number of patents.” (Read More)
When it comes to epilepsy, CBD and cannabis therapies are becoming more and more paramount. In this article from Fox on the work of CBD with Epilepsy:
“Researchers are now hailing a compound in marijuana as a “game-changing medication” for epilepsy. Based on testimonials from parents, Orrin Devinsky of NYU’s Comprehensive Epilepsy Center set out to find proof that epilepsy could be treated with cannabidiol (CBD)—and he says he did.
In a 14-week study, 60 kids and teens with a severe form of epilepsy known as Dravet syndrome were given doses of CBD and saw their number of monthly convulsive seizures fall from 12 on average to about six, reports Live Science.
Three patients saw their seizures stop entirely, the researchers say in the New England Journal of Medicine. One downside: Almost all patients who took CBD reported side effects, including vomiting and diarrhea, per Scientific American.
(CBD doesn’t get users high.) But 62 percent of caregivers said the condition of the child in their care improved overall. That’s compared to 34 percent of caregivers of children who took a placebo, who went from having about 15 monthly seizures to about 14.
Given this study and others, Devinsky says it’s “medieval” that marijuana is deemed a Schedule I substance under the Controlled Substances Act. Drugs in this category have “no currently accepted medical use,” according to the Drug Enforcement Administration, but that’s “simply untrue,” he says.
“To put CBD as a Schedule I drug violates scientific data and common sense.” (More on CBD and epilepsy here.)